Do Helper T Cell Subtypes in Lymphocytic Thyroiditis Play a Role in the Antitumor Effect?

Area of Science:

• Immunology
• Oncology
• Endocrinology

Background:

• Papillary thyroid carcinoma (PTC) often co-occurs with lymphocytic thyroiditis (LT).
• Existing research presents conflicting views on whether LT enhances PTC risk or possesses antitumor properties.
• Understanding the role of helper T cell (Th) cytokines in PTC with LT is crucial.

Purpose of the Study:

• To investigate the relationship between Th cytokine patterns in PTC with and without LT.
• To correlate these cytokine patterns with clinicopathological manifestations of PTC.

Main Methods:

• Analysis of fresh surgical samples from PTC patients with (13) and without (10) LT.
• Assessment of prognostic parameters: tumor size, extra-thyroidal extension, and lymph node metastasis.
• Quantification of Th1 (TNF-α, IFN-γ, IL-2) and Th2 (IL-4, IL-10) cytokine mRNA levels, using p27 as a surrogate marker for lymph node metastasis.

Main Results:

• PTC cases with LT exhibited significantly higher expression of TNF-α, IFN-γ, and IL-4 compared to PTC without LT.
• Higher expression of most analyzed cytokines (except IL-4) was observed in cases with a higher p27 surrogate marker score, suggesting a link to reduced metastasis.

Conclusions:

• Mixed Th1 and Th2 immune responses in PTC with LT may contribute to an antitumor effect.
• This immune interplay appears to be associated with a reduced likelihood of lymph node metastasis in papillary thyroid carcinoma.